The High Cost Drugs Subgroups (HCDSG) were previously responsible for the development and update of pathways and commissioning statements relating to specified high cost drugs (i.e., PbR-excluded drugs). At certain points these functions were split between the High Cost Drugs Operational Group (HCDOG) and High Cost Drugs Strategic Group (HCDStG).

Minutes from meetings of these groups are available below.

Document Title Issue Date Review Date Status
HCDSG minutes August 2020 20200903 Sep 2020 Approved
HCDSG minutes June 2020 20200803 Aug 2020 Approved
HCDSG minutes February 2020 20200803 Aug 2020 Approved
HCD Strategic Group minutes November 2019 20200203 Feb 2020 Approved
HCD Operational Group minutes November 2019 20200203 Feb 2020 Approved
HCD Operational Group minutes October 2019 20191103 Nov 2019 Approved
HCD Strategic Group minutes September 2019 20191103 Nov 2019 Approved
HCD Operational Group minutes September 2019 20191003 Oct 2019 Approved
HCD Operational Group minutes August 2019 20190903 Sep 2019 Approved
HCD Operational Group minutes July 2019 20190803 Aug 2019 Approved
HCDSG minutes June 2019 20190703 Jul 2019 Approved
HCDSG minutes April 2019 20190603 Jun 2019 Approved
HCDSG minutes March 2019 20190403 Apr 2019 Approved
HCDSG minutes February 2019 20190303 Mar 2019 Approved
HCDSG minutes October 2018 20190203 Feb 2019 Approved
HCDSG minutes September 2018 20181003 Oct 2018 Approved
HCDSG minutes August 2018 20180903 Sep 2018 Approved
HCDSG minutes June 2018 20180803 Aug 2018 Approved
HCDSG minutes May 2018 20210603 Jun 2021 Approved
HCDSG minutes April 2018 20180503 May 2018 Approved
HCDSG minutes March 2018 20180403 Apr 2018 Approved
HCDSG minutes January 2018 20180303 Mar 2018 Approved